Januvia Pancreatitis Problems Refuted by Merck
Following an FDA alert issued Friday about reports of acute pancreatitis associated with use of Januvia and Janumet, Merck & Co., the maker of both diabetes drugs, issued a statement refuting that...
View ArticleOnglyza Side Effects Raise Concerns for Consumer Group Public Citizen
The consumer watchdog group Public Citizen is raising questions about the effectiveness and possible side effects of Onglyza, a relatively new diabetes drug. In their monthly newsletter, Worst Pills...
View ArticleJanuvia Pancreatitis Risk Not Adequately Studied by Merck: FDA
According to federal drug regulators, Merck failed to conduct requested testing on their popular diabetes drugs Januvia and Janumet, which was designed to review the potential impact of the medications...
View ArticleJanuvia Lawsuits
Use of the diabetes drug Januvia has been linked to reports of serious and potentially life-threatening side effects, including pancreatic cancer and pancreatitis. JANUVIA LAWSUIT STATUS: Lawyers are...
View ArticleJanuvia, Byetta Pancreatic Cancer Risk Review Launched by FDA
The FDA has launched an investigating into the possibility that diabetics may face an increased risk of pancreatitis and pancreatic cancer from an entire class of diabetes drugs, which includes...
View ArticlePancreatic Cancer Lawsuit Filed Over Janumet, Victoza and Byetta Use
A Louisiana woman has filed a lawsuit against the makers of three different diabetes drugs, alleging that she developed pancreatic cancer from Janumet, Victoza and Byetta. The compaint (PDF) was filed...
View ArticleAmid Pancreatitis and Pancreatic Cancer Concerns, Januvia Sales Plunge
As concerns have mounted in recent months about the risk of pancreatitis and pancreatic cancer from Januvia, sales of Merck’s blockbuster diabetes drug have taken a sudden dive, contributing to...
View ArticleAmylin, Eli Lilly Support Centralization of Byetta Pancreatic Cancer Lawsuits
In response to a request filed last month by a group of plaintiffs asking to consolidate all Byetta lawsuits, Januvia lawsuits, Janumet lawsuits and Victoza lawsuits filed in the federal court system...
View ArticlePancreatic Cancer Wrongful Death Lawsuit Filed Over Diabetes Drugs
A wrongful death lawsuit has been filed by the family of a California woman, which alleges that their mother developed pancreatic cancer from side effects of the diabetes drugs Byetta, Bydureon,...
View ArticleByetta Thyroid Cancer Lawsuit Filed Against Amylin, Eli Lilly
A Virginia woman has filed a product liability lawsuit against Amylin Pharmaceuticals and Eli Lilly & Co., alleging that she developed thyroid cancer from side effects of Byetta, a popular diabetes...
View ArticleByetta, Januvia Pancreatic Cancer Risk Needs Independent Review: ADA
The American Diabetes Association (ADA) is calling for an independent review of all available data involving potential side effects of incretin mimetic diabetes drugs, which include popular medications...
View ArticleDrug Makers to Present New Byetta Data At Diabetes Conference
Two drug manufacturers are planning to present data on a number of new studies involving the effectiveness and safety of a class of diabetes drugs that includes Byetta and Januvia, which have been the...
View ArticleByetta Pen Lawsuit Filed After Pancreatic Cancer Diagnosis
A Louisiana woman has filed a lawsuit against Amylin Pharmaceuticals and Eli Lilly and Co., alleging that she developed pancreatic cancer from the diabetes Byetta pen. The complaint (PDF) was filed by...
View ArticlePancreatic Cancer Lawsuit Over Byetta, Victoza Remanded to State Court
A lawsuit filed by a California woman who alleges that she developed pancreatic cancer from Byetta and Victoza side effects is being sent back to state court, after a federal judge determined that a...
View ArticleJanuvia Problems Likely to Continue to Impact Merck: Report
A Wall Street analyst is warning investors that Merck may be headed into troubled waters due to problems with Januvia, its blockbuster diabetes drug. Sales of Januvia declined by 4% in the first...
View ArticleByetta, Januvia Pancreatic Cancer Review Results in No Change for EMA
In response to growing concerns among consumers and the medical community, European drug regulators have indicated that a review has failed to confirm any link between a risk of pancreatic cancer and...
View ArticleFDA Finds No Pancreatic Cancer Risk in Byetta, Januvia
Federal drug regulators in the U.S. are echoing the recent findings of European reviewers, stating that they have been unable to confirm an increased risk of pancreatic cancer linked to side effects of...
View ArticleNovo Nordisk Sales Remain Strong, Even Amid Victoza Cancer Concerns
The drug maker Novo Nordisk indicates that their large profits this quarter are mainly due to strong sales for Victoza, a controversial diabetes drug that has been linked to concerns about a risk of...
View ArticleByetta, Januvia Lawsuits Over Pancreatic Cancer Continue to Roll In
The number of pancreatic cancer lawsuits filed against the makers of Byetta, Januvia, Janumet and Victoza continue to increase, despite recent doubts raised by federal regulators about evidence linking...
View ArticleSide Effects of Metformin May Cause Problems With Thinking: Study
The findings of a new study raises potential concerns about the side effects of meformin, suggesting that the popular diabetes drug may impair brain functions and cause users to experience problems...
View Article
